Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy.

Abstract

We retrospectively investigated the outcome of ovarian cancer in women aged less than 40 years treated in three randomised phase III studies of platinum-based chemotherapy. 624 patients had invasive epithelial ovarian cancer. A Cox proportional hazard model was used to study prognostic variables. 29 women (5%) were under 40 years of age. Stage, histological grade and amount of residual disease were significantly worse in women aged > or = 40 years. Median follow-up was 66.7 months. At 5 years 65% of women below 40 years of age were alive compared with 20% of older women (95% confidence interval (CI) of the difference 27.1-63.0). The progression-free interval was 59% versus 16% (95% CI 24.3-60.8). No patient under 40 years of age relapsed after 18 months. Age > or = 40 years was a poor prognostic variable, particularly for serous tumours, the commonest subtype in younger women (hazard ratio (HR): 3.33). Other prognostic factors were Eastern Cooperative Oncology Group (ECOG) performance status (HR: 1.25), presence of residual disease (HR: 1.43), histological grade (HR: 1.36) and International Federation of Gynaecology and Obstetrics (FIGO) stage (HR: 1.47). These results suggest that there are biological differences in the behaviour of serous carcinoma of the ovary in women of reproductive age compared with older women.

Statistics

050'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

66 Citations

Semantic Scholar estimates that this publication has 66 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Lee1999OutcomeOE, title={Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy.}, author={Ch. K. Lee and Marta Pires de Miranda and Jonathan A. Ledermann and Mary Carmen Ruiz de Elvira and A. E. Nelstrop and Hovey Lambert and Gordon John Sampson Rustin and Colin W Trask}, journal={European journal of cancer}, year={1999}, volume={35 5}, pages={727-32} }